Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab

Trial Profile

Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 Jan 2019

At a glance

  • Drugs Tocilizumab (Primary) ; Tocilizumab (Primary) ; Methylprednisolone
  • Indications Giant cell arteritis
  • Focus Therapeutic Use
  • Acronyms GUSTO
  • Most Recent Events

    • 15 Jan 2019 Status changed from not yet recruiting to recruiting.
    • 27 Nov 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top